Clinical Trials Browser

Phase 2 × Thrombosis × apixaban × Clear all

NCT00320255 2016-08-16

A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer

Phase 2 Completed

130 enrolled 22 charts

Neoplasms, Pulmonary Embolism, Thrombosis